Ohcanbohtosat - Bot, Adrian

New section in journal of translational medicine: patient-targeted molecular therapies Dahkki Bot, Adrian, Chiappelli, Francesco

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

JTM’s Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section Dahkki Bot, Adrian, Marincola, Francesco, Romero, Pedro

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Protective Role of Gamma Interferon during the Recall Response to Influenza Virus Dahkki Bot, Adrian, Bot, Simona, Bona, Constantin A.

Viečča ollesdeavstta Viečča ollesdeavstta

Cancer vaccines at an inflexion point: what next? Dahkki Bot, Adrian, Obrocea, Mihail, Marincola, Francesco M

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Protective Cellular Immunity Against Influenza Virus Induced by Plasmid Inoculation of Newborn Mice Dahkki Bot, Adrian, Bot, Simona, García-Sastre, Adolfo, Bona, Constantin

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8(+ )T cell immunity Dahkki Bot, Adrian, Qiu, Zhiyong, Wong, Raymond, Obrocea, Mihail, Smith, Kent A

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination Dahkki Wang, Lilin, Smith, Dan, Bot, Simona, Dellamary, Luis, Bloom, Amy, Bot, Adrian

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors Dahkki Weber, Jeffrey S., Vogelzang, Nicholas J., Ernstoff, Marc S., Goodman, Oscar B., Cranmer, Lee D., Marshall, John L., Miles, Sabrina, Rosario, Dar, Diamond, David C., Qiu, Zhiyong, Obrocea, Mihail, Bot, Adrian

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Dahkki Kochenderfer, James N., Somerville, Robert P.T., Lu, Tangying, Yang, James C., Sherry, Richard M., Feldman, Steven A., McIntyre, Lori, Bot, Adrian, Rossi, John, Lam, Norris, Rosenberg, Steven A.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Target discovery for T cell therapy: next steps to advance Immunotherapies Dahkki Bot, Adrian, Brewer, Joanna E, Eshhar, Zelig, Frankel, Stanley R, Hickman, Emma, Jungbluth, Achim A, Morgan, Richard, Peretz, Yoav, Radvanyi, Laszlo, Ramos, Carlos A, Robbins, Paul F, Wucherpfennig, Kai W

Viečča ollesdeavstta Viečča ollesdeavstta

Antigen kinetics determines immune reactivity Dahkki Johansen, Pål, Storni, Tazio, Rettig, Lorna, Qiu, Zhiyong, Der-Sarkissian, Ani, Smith, Kent A., Manolova, Vania, Lang, Karl S., Senti, Gabriela, Müllhaupt, Beat, Gerlach, Tilman, Speck, Roberto F., Bot, Adrian, Kündig, Thomas M.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy Dahkki Chen, Pei-Hsuan, Lipschitz, Mikel, Weirather, Jason L., Jacobson, Caron, Armand, Philippe, Wright, Kyle, Hodi, F. Stephen, Roberts, Zachary J., Sievers, Stuart A., Rossi, John, Bot, Adrian, Go, William, Rodig, Scott J.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL Dahkki Rossi, John, Paczkowski, Patrick, Shen, Yueh-Wei, Morse, Kevin, Flynn, Brianna, Kaiser, Alaina, Ng, Colin, Gallatin, Kyle, Cain, Tom, Fan, Rong, Mackay, Sean, Heath, James R., Rosenberg, Steven A., Kochenderfer, James N., Zhou, Jing, Bot, Adrian

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A critical role for fas-mediated off-target tumor killing in T cell immunotherapy Dahkki Upadhyay, Ranjan, Boiarsky, Jonathan A., Pantsulaia, Gvantsa, Svensson-Arvelund, Judit, Lin, Matthew J., Wroblewska, Aleksandra, Bhalla, Sherry, Scholler, Nathalie, Bot, Adrian, Rossi, John M., Sadek, Norah, Parekh, Samir, Baccarini, Alessia, Merad, Miriam, Brown, Brian D., Brody, Joshua D.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma Dahkki Locke, Frederick L., Neelapu, Sattva S., Bartlett, Nancy L., Siddiqi, Tanya, Chavez, Julio C., Hosing, Chitra M., Ghobadi, Armin, Budde, Lihua E., Bot, Adrian, Rossi, John M., Jiang, Yizhou, Xue, Allen X., Elias, Meg, Aycock, Jeff, Wiezorek, Jeff, Go, William Y.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma Dahkki Locke, Frederick L., Rossi, John M., Neelapu, Sattva S., Jacobson, Caron A., Miklos, David B., Ghobadi, Armin, Oluwole, Olalekan O., Reagan, Patrick M., Lekakis, Lazaros J., Lin, Yi, Sherman, Marika, Better, Marc, Go, William Y., Wiezorek, Jeffrey S., Xue, Allen, Bot, Adrian

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Lymph Node-Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic HPV-Transformed Tumors Dahkki Smith, Kent A., Meisenburg, Brenna L., Tam, Victor L., Pagarigan, Robb R., Wong, Raymond, Joea, Diljeet K., Lantzy, Liz, Carrillo, Mayra A., Gross, Todd M., Malyankar, Uriel M., Chiang, Chih-Sheng, Da Silva, Diane M., Kündig, Thomas M., Kast, W. Martin, Qiu, Zhiyong, Bot, Adrian

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies Dahkki Bot, Adrian, Ahn, Mark, Bosch, Marnix, Brockstedt, Dirk, Butterfield, Lisa H, Cornforth, Andrew, Harrop, Richard, Kast, W Martin, Koya, Richard, Marincola, Francesco, Margolin, Kim, McCoy, Candice, Pawelec, Graham, Rothman, John, Ramirez-Montagut, Teresa, Schlom, Jeffrey, Srivastava, Pramod, Wallis, Sarah, Walter, Steffen, Wang, Ena, Waslif, John

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Safety and feasibility of anti-CD19 CAR T cells with fully-human binding domains in patients with B-cell lymphoma Dahkki Brudno, Jennifer N., Lam, Norris, Vanasse, Danielle, Yueh-wei, Shen, Rose, Jeremy J., Rossi, John, Xue, Allen, Bot, Adrian, Scholler, Nathalie, Mikkilineni, Lekha, Roschewski, Mark, Dean, Robert, Cachau, Raul, Youkharibache, Philippe, Patel, Rashmika, Hansen, Brenna, Stroncek, David F., Rosenberg, Steven A., Gress, Ronald E., Kochenderfer, James N.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma Dahkki Brudno, Jennifer N., Lam, Norris, Vanasse, Danielle, Shen, Yueh-wei, Rose, Jeremy J., Rossi, John, Xue, Allen, Bot, Adrian, Scholler, Nathalie, Mikkilineni, Lekha, Roschewski, Mark, Dean, Robert, Cachau, Raul, Youkharibache, Philippe, Patel, Rashmika, Hansen, Brenna, Stroncek, David F., Rosenberg, Steven A., Gress, Ronald E., Kochenderfer, James N.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta